MOLECULES WITH EXTENDED HALF LIVES, COMPOSITIONS AND USES THEREOF

The present invention provides molecules, including IgGs, non-IgG immunoglobulins, proteins and non-protein agents, that have increasedin vivohalf-lives due to the presence of an IgG constant domain, or a portion thereof that binds the FcRn, having one or more amino acid modifications that increase...

Full description

Saved in:
Bibliographic Details
Main Authors WARD, Elizabeth Sally, DALL'ACQUA, William, JOHNSON, Leslie S
Format Patent
LanguageEnglish
French
German
Published 18.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides molecules, including IgGs, non-IgG immunoglobulins, proteins and non-protein agents, that have increasedin vivohalf-lives due to the presence of an IgG constant domain, or a portion thereof that binds the FcRn, having one or more amino acid modifications that increase the affinity of the constant domain or fragment for FcRn. Such proteins and molecules with increased half-lives have the advantage that smaller amounts and or less frequent dosing is required in the therapeutic, prophylactic or diagnostic use of such molecules.
Bibliography:Application Number: EP20190153658